Search clinical trials for: Advanced bladder cancer
Total 96776 results
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Bladder Cancer | Stage IV Bladder Cancer | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage... and other conditionsUnited States
-
Cairo UniversityCompleted
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Prof. Dr. Thomas OttoCompletedAdvanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.Germany
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerNetherlands
-
University of KentuckyBayerTerminated
-
Cadila PharnmaceuticalsCompleted
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Asan Medical CenterSamsung Medical Center; Kangdong Sacred Heart HospitalCompletedBladder Cancer | Ureter CancerKorea, Republic of
-
Roger Williams Medical CenterBeth Israel Deaconess Medical CenterCompleted
-
Institut CurieCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterFrance
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
Iwate Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Institut du Cancer de Montpellier - Val d'AurelleSuspended
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
Celldex TherapeuticsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Bladder CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
Halozyme TherapeuticsCompletedSuperficial Bladder CancerUnited States
-
Poniard PharmaceuticalsCompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Gastrointestinal NeoplasmUnited States
-
Achieve Life SciencesCompletedCarcinoma, Transitional Cell | Ureteral Neoplasms | Urethral Neoplasms | Bladder NeoplasmsUnited States
-
Pharmacyclics LLC.CompletedGastrointestinal Neoplasms | Breast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Ovarian NeoplasmsUnited States
-
Helsinn Healthcare SATerminatedBiliary Tract CancerUnited States, Spain, Canada, France, Germany, Hungary, Italy, Belgium, Poland, Russian Federation, United Kingdom
-
Millennium Pharmaceuticals, Inc.TerminatedBreast Neoplasm | Pancreatic Neoplasm | Colon Neoplasm | Bladder NeoplasmUnited States
-
NovaceaUnknownNon-Hodgkin's Lymphoma | Solid MalignanciesUnited States
-
Association of Urologic Oncology (AUO)Eli Lilly and CompanyUnknownCarcinoma, Transitional Cell | Bladder CancerGermany
-
Eli Lilly and CompanyCompletedCarcinoma, Transitional CellUnited States
-
Eli Lilly and CompanyCompletedUrologic NeoplasmsFinland, France, Germany
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Metastases, NeoplasmUnited States
-
Tianjin Medical University Cancer Institute and...Not yet recruitingESCC | Advanced Esophageal Squamous Cell CarcinomaChina
-
Bristol-Myers SquibbRecruitingNon-small Cell Lung Cancer (NSCLC)Italy
-
University of FloridaNot yet recruiting
-
Rui-hua Xu, MD, PhDNot yet recruitingEsophageal Squamous Cell CarcinomaChina
-
FBD Biologics LimitedNot yet recruitingRefractory Hodgkin Lymphoma | Advanced Solid Tumor
-
Shanghai Pudong HospitalImmuXell Biotech Ltd.RecruitingColorectal Cancer | Pancreatic CancerChina
-
MedSIRNot yet recruitingAdvanced Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Advanced Breast Carcinoma
-
Hunan Cancer HospitalNot yet recruitingAdvanced Gastric Cancer
-
Changzhi People's Hospital Affiliated to Changzhi...RecruitingGastric Cancer | PD-1 Immunotherapy | RWSChina
-
Shenzhen TargetRx, Inc.Sir Run Run Shaw HospitalNot yet recruitingNon Small Cell Lung Cancer | Advanced Solid Tumor | Hematologic Malignancy
-
Axter Therapeutics (Beijing) Co., LtdNot yet recruitingNon-Hodgkin Lymphoma | Advanced Solid TumorChina
-
Wuhan Union Hospital, ChinaNot yet recruitingTo Evaluate the Efficacy of Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Colorectal Carcinoma | To Evaluate Whether Pirfenidone Can Reshape the Tumor Microenvironment in Colorectal Cancer | Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to...
-
Ting DengNeowise BiotechnologyRecruiting
-
Iovance Biotherapeutics, Inc.Not yet recruiting
-
Chongqing University Cancer HospitalRecruiting
-
West China HospitalRecruitingLocally Advanced Thyroid Gland CarcinomaChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Qun ZhaoRecruiting1. Locally Advanced Gastric Cancer (LAGC): The Primary Condition Under Investigation is Locally Advanced Gastric Cancer, Which Refers to StomachChina